Relmada Therapeutics, Inc. (RLMD)
7.01
+0.26
(+3.85%)
USD |
NASDAQ |
Apr 08, 16:00
7.01
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics Shareholders Equity (Quarterly) : 86.51M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 954.27M |
| Theravance Biopharma, Inc. | 296.72M |
| Avalo Therapeutics, Inc. | 83.05M |
| AN2 Therapeutics, Inc. | 53.06M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 94.00M |
| Total Liabilities (Quarterly) | 7.492M |
| Current Ratio | 14.62 |